Edition:
India

Taisho Pharmaceutical Holdings Co Ltd (4581.T)

4581.T on Tokyo Stock Exchange

9,990JPY
19 Apr 2019
Change (% chg)

¥40 (+0.40%)
Prev Close
¥9,950
Open
¥10,020
Day's High
¥10,100
Day's Low
¥9,950
Volume
67,400
Avg. Vol
104,433
52-wk High
¥14,130
52-wk Low
¥9,920

About

TAISHO PHARMACEUTICAL HOLDINGS CO., LTD. is a holding company mainly engaged in the manufacture and sale of pharmaceuticals. The Self-Medication segment is engaged in the research, development, manufacture and sale of general pharmaceuticals, general foods, medical supplies and others. The Medical segment is engaged in the... (more)

Overall

Beta: 0.42
Market Cap(Mil.): ¥900,495.12
Shares Outstanding(Mil.): 90.14
Dividend: 60.00
Yield (%): 1.10

Financials

  4581.T Industry Sector
P/E (TTM): 14.10 62.06 62.40
EPS (TTM): 708.72 -- --
ROI: 7.87 12.17 11.78
ROE: 8.17 13.11 12.61

Bristol-Myers gets $1.6 billion offer for French consumer health unit

Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

UPDATE 2-Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Bristol-Myers gets $1.6 bln offer for French consumer health unit

Dec 19 Bristol-Myers Squibb Co received an offer from Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd to buy the company's French over-the-counter drugs business UPSA for $1.6 billion, the companies said on Wednesday.

19 Dec 2018

Deals of the day-Mergers and acquisitions

Dec 17 The following bids, mergers, acquisitions and disposals were reported by 2100 GMT on Monday:

18 Dec 2018

Taisho said to near $1.6 billion deal for Bristol-Myers's UPSA: Bloomberg

Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Taisho said to near $1.6 bln deal for Bristol-Myers's UPSA- Bloomberg

Dec 16 Japanese healthcare firm Taisho Pharmaceutical Holdings Co Ltd is said to be close to a $1.6 billion deal for Bristol-Myers Squibb Co's French over-the-counter drugs business UPSA, Bloomberg reported on Sunday, citing sources familiar with the matter.

17 Dec 2018

Earnings vs. Estimates